Bioscience Animal Health plans IPO for expansion


Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, is planning an initial public offering (IPO) in Q2 2022 to raise funds for expansion. BIS CEO Dhanawat Khongjaroensombat said the company will invest in a pig vaccine development program with the National Science Techno...

Sign in  as a member, or Join our Community  for free to unlock the full article.